Isareli diagnostics company developing blood-based CRC test — 4 insights

Todos Medical wants to follow in the competition's footsteps in developing and promoting its blood-based colorectal cancer test, CEO Herman Weiss, MD, said in an update on the state of the company at a conference in Los Angeles.

What you should know:

1. Todos is developing TM-C1, a blood-based diagnostic test for colon cancer.

2. Todos is in the midst of studying TM-C1.

3. When elaborating on the next steps for TM-C1, Dr. Weiss referenced Exact Sciences' developmental path.

"Exact Sciences has shown successful adoption for their colon cancer stool test and we believe we can replicate their roadmap to success with a simple blood test," Dr. Weiss said.

4. The company has blood-based tests for breast and other cancers in development.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers

Featured Podcast